<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04811183</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL21_0197</org_study_id>
    <nct_id>NCT04811183</nct_id>
  </id_info>
  <brief_title>Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital</brief_title>
  <acronym>EPHET</acronym>
  <official_title>Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators hypothesize that the implementation of a hospital pharmacy consultation and the&#xD;
      transmission of its report to pharmacies may improve knowledge, adherence and encourage the&#xD;
      development of pharmacist medication reviews. A before-and-after study of the implementation&#xD;
      of pharmaceutical consultations will allow the investigators to evaluate the validity of the&#xD;
      hypothesis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution in the knowledge about the patient's condition</measure>
    <time_frame>One week</time_frame>
    <description>Treatment knowledge, knowledge about the pathology and knowledge of hygienic and dietary measures will be assessed with a questionnaire giving a score from 0 to 2 -the higher the score, the better the outcome-.&#xD;
Comparison of the knowledge of the treatment between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation.&#xD;
Statistical evaluation by comparative tests between the two questionnaires.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution in the adherence</measure>
    <time_frame>One week</time_frame>
    <description>Evaluation of the patient's adherence to his treatment through a questionnaire giving a score between 0 to 6 -the higher the score, the better the outcome-. Comparison of the scores between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation.&#xD;
Statistical evaluation by comparative tests between the two questionnaires.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <description>Adult patients hospitalized with diabetes and polymedicated. Selected to benefit from a pharmaceutical consultation before their return home.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmaceutical consultation</intervention_name>
    <description>Selection of patients for a pharmaceutical consultation with collection of non-opposition and scheduling of telephone interviews or by teleconsultations at one week after hospitalization.&#xD;
Data collection through interviews using a telephone questionnaire (or by teleconsultation) one week after consultation. Elements on knowledge and adherence of treatment will be collected.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than&#xD;
        5 concomitting treatments, on the way to returning home.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more&#xD;
             than 5 concomitant treatments&#xD;
&#xD;
          -  Adult patient that is being discharged for a return home&#xD;
&#xD;
          -  Good comprehension of French&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bad comprehension of French&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier DODE</last_name>
    <phone>04 72 35 71 08</phone>
    <email>xavier.dode@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olivier RIBES</last_name>
    <phone>04 72 39 22 43</phone>
    <email>olivier.ribes@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HÃ´pital Louis Pradel</name>
      <address>
        <city>Bron</city>
        <zip>69577</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier DODE, MD</last_name>
      <phone>04 72 35 71 08</phone>
      <email>xavier.dode@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pharmaceutical consultations</keyword>
  <keyword>adherence</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

